B

BioInvent International AB
STO:BINV

Watchlist Manager
BioInvent International AB
STO:BINV
Watchlist
Price: 31.55 SEK -0.16% Market Closed
Market Cap: 2.1B SEK

Wall Street
Price Targets

BINV Price Targets Summary
BioInvent International AB

Wall Street analysts forecast BINV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BINV is 81.6 SEK with a low forecast of 80.8 SEK and a high forecast of 84 SEK.

Lowest
Price Target
80.8 SEK
156% Upside
Average
Price Target
81.6 SEK
159% Upside
Highest
Price Target
84 SEK
166% Upside
BioInvent International AB Competitors:
Price Targets
ANAB
AnaptysBio Inc
116% Upside
SPRY
ARS Pharmaceuticals Inc
132% Upside
DVAX
Dynavax Technologies Corp
83% Upside
BIOCON
Biocon Ltd
16% Upside
NTRA
Natera Inc
34% Upside
CMRX
Chimerix Inc
3% Upside
300142
Walvax Biotechnology Co Ltd
4% Downside
STOK
Stoke Therapeutics Inc
192% Upside

Revenue
Forecast

Revenue Estimate
BioInvent International AB

For the last 8 years the compound annual growth rate for BioInvent International AB's revenue is 21%. The projected CAGR for the next 4 years is 68%.

21%
Past Growth
68%
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BioInvent International AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
BioInvent International AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BINV's stock price target?
Price Target
81.6 SEK

According to Wall Street analysts, the average 1-year price target for BINV is 81.6 SEK with a low forecast of 80.8 SEK and a high forecast of 84 SEK.

What is BioInvent International AB's Revenue forecast?
Projected CAGR
68%

For the last 8 years the compound annual growth rate for BioInvent International AB's revenue is 21%. The projected CAGR for the next 4 years is 68%.

Back to Top